Major players in the diabetic footwear market are Podartis Srl, DJO Global Inc. , Aetrex Worldwide Inc. , Dr. Zen Products Inc, Orthofeet Inc. , Dr. Comfort llc, Drew Shoes, New Balance Inc. , I-Runner, Finn Comfort, Pilgrim shoes, Diabetic Soles Inc.

New York, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Diabetic Footwear Global Market Report 2022" - https://www.reportlinker.com/p06318571/?utm_source=GNW , Hanger Inc., and Hush Puppies Retail Inc. The global diabetic footwear market is expected to grow from $6.34 billion in 2021 to $7.07 billion in 2022 at a compound annual growth rate (CAGR) of 11.4%. The diabetic footwear market is expected to grow to $9.57 billion in 2026 at a CAGR of 7.9%. The diabetic footwear market consists of the sales of diabetic footwear by entities (organizations, sole traders, and partnerships) that are used to relieve pressure and calluses on the bottom of the foot.Diabetic footwear refers to therapeutic footwear that is broader and deeper than conventional shoes and made of special protective inserts and soft materials. It includes a larger toe box to avoid squeezing the toes and reduce the possibility of bottom blisters (ulcers) produced by disunion and pressure. The main types of diabetic footwear are shoes, sandals, and slippers.The diabetic shoes are made of special protective inserts and soft materials and are used for increasing blood circulation and nerve sensation, having a wide toe box, and massaging to reduce pressure. The various distribution channels include online platforms, specialty stores, footwear stores, and others and are used by various end-users, including men, women. North America was the largest region in the diabetic footwear market in 2021. The regions covered in the diabetic footwear market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The diabetic foot wear market research report is one of a series of new reports that provides diabetic foot wear market statistics, including global market size, regional shares, competitors with a diabetic foot wear market share, detailed diabetic foot wear market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic foot wear industry. This diabetic foot wear market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry. The increasing number of diabetic patients will propel the growth of the diabetic footwear market going forward.Diabetes is a chronic health condition that results in high blood glucose levels. Diabetic footwear can help prevent serious foot health complications that can arise as a result of diabetes and also provide the necessary benefits such as increased blood circulation, a wide toe box, and massaging to reduce pressure in the areas of the foot that are most susceptible to pain.For instance, in 2021, according to the report published by the International Diabetes Federation, a Belgium-based umbrella organization of 230 national diabetes associations, there were 463 million and 537 million people suffering from diabetes around the world in 2019 and 2021, respectively. Also, by 2030, the overall number of diabetics is expected to reach 643 million, and by 2045, it will reach 783 million. Therefore, the increasing number of diabetic patients is driving the growth of the diabetic footwear market. Technological advancements are a key trend gaining popularity in the diabetic footwear market.Major companies operating in the diabetic footwear market are developing new technologies to strengthen their position in the market. For instance, in December 2021, Von Wellx, a Germany-based company that specializes in footwear that provides health benefits, launched diabetic footwear based on reflex zones technology.The footwear functions by massaging the pressure points in the foot, similar to walking barefoot on grass, stimulating blood circulation and oxygen, thereby energizing the body and resulting in minimal exhaustion throughout the day, even when standing and walking for 12 hours or more. It also gives the benefit of walking 8000 steps with only 3000 steps because the spring and massaging function work the user’s foot muscles 2.5 times per step. In November 2021, Aiglon Capital and Merit Capital, a US-based private infrastructure firm, acquired Propét for an undisclosed amount.The acquisition is anticipated to improve the position, provide Aiglon and Merit with a solid base, and open up new opportunities for brand expansion. Propet is a US-based company that manufactures comfort footwear and diabetic footwear. The countries covered in the diabetic footwear market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. Read the full report: https://www.reportlinker.com/p06318571/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________

Nursing homes and debt collectors are billing and suing long-term-care residents’ family members and friends, demanding payments for debts these individuals don’t legally owe, consumer attorneys and federal regulators are claiming. Under federal law, nursing homes participating in Medicare and Medicaid can’t make such provisions a condition of admission or continued stay in the facility.

Regeneron's Eylea eye-disorder drug faces competitive pressure on multiple fronts. New data could cement its dominance.

When planning for the future, health care ranks as one of the highest concerns for both savers and retirees alike. Not only are health care costs rising by more than 5% every year, but rampant inflation and volatile market performances … Continue reading → The post New Bill May Allow Penalty-Free 401(k) Withdrawals for This Retirement Expense appeared first on SmartAsset Blog.

FDA approves AstraZeneca's (AZN) Imfinzi combination for advanced metastatic biliary tract cancer and grants Breakthrough Therapy Designation to Pfizer's (PFE) Group B Streptococcus (GBS) vaccine.

These strategies can help you reduce your health care costs.

Studies "support aflibercept 8 mg as a potential new standard-of-care," Regeneron Pharmaceuticals said. Regeneron stock leapt in huge volume.

Shares of Shuttle Pharmaceuticals Holdings (NASDAQ: SHPH) climbed 160.4% this week, according to data from S&P Global Intelligence. The stock closed at $14.90 last Friday and then opened this Tuesday at $12.16. The stock began trading on Aug. 31 after its initial public offering (IPO).

Apellis' (APLS) marketed drug, Empaveli, approved for treating paroxysmal nocturnal hemoglobinuria is driving revenues. The drug's label expansion studies also hold promise.

Amgen's biosimilar drug is close to stealing away sales from AstraZeneca's rare disease drug called Soliris.

The FDA's PCNSDAC recommends granting marketing approval to Amylyx's (AMLX) oral drug, which slows the progression of ALS.

It seems like every major technology company wants to disrupt healthcare. It's easy to see why as the United States spends nearly 18% of its gross domestic product (GDP) on healthcare. "...Because national health expenditures are projected to grow 1.1 percentage points faster than gross domestic product per year on average over 2019-28, the health share of the economy is projected to rise from 17.7% in 2018 to 19.7% in 2028."

Amylyx Pharmaceuticals Inc. shares were riding high in the first few hours of trading following a key FDA advisory committee's positive vote on its first drug, despite the unusual caveats that accompanied the vote.

Parkinson's disease (PD) may be an issue that stems from the health and function of your brain, according to the National Institute on Aging. However, a new study recently published by JAMA Network Open also reveals a connection between eating habits and mortality rates for those with PD.In a study titled "Association of Diet and Physical Activity With All-Cause Mortality Among Adults With Parkinson Disease," researchers took a look at 1,251 participants who were previously diagnosed with Parkin

An emerging crop of drug developers is using artificial intelligence, machine learning, and sometimes supercomputers to design safer and more effective drugs. The latest update from Relay Therapeutics provides early validation for a technology-enabled approach. At the very least, the preliminary data published ahead of an important scientific meeting shows the promise of the company's unique strategy to design more selective drug candidates.

An Etowah County, Alabama, jail is detaining several pregnant women and new moms for allegedly using drugs while pregnant. None of the women, at least two of whom are Black, have been convicted despite being held in jail for months.

A Pennsylvania woman is claiming that she spent four days in the hospital after biting into a scrap of metal in her chicken fries order from Burger King.

Scott Taylor never got to move on from COVID-19. The analysis was based on data from 20 major U.S. hospital systems, including more than 1.3 million adults with a COVID diagnosis and 19,000 with a long COVID diagnosis between May 2020 and July 2022.

Medicare is designed to help eligible individuals pay for healthcare. One of the most important decisions to make when enrolling for the first time or making changes to your coverage during open enrollment is whether to opt for Medicare Advantage … Continue reading → The post Medicare Open Enrollment Is Almost Closed: Medicare Advantage vs. Medicare appeared first on SmartAsset Blog.

Yep, you can score major health benefits from walking along to a soundtrack of just one song on your playlist!

A Democratic congresswoman in a key swing district in Virginia is pushing to take advantage of a backlash to the Supreme Court’s abortion ruling to fend off a Republican challenger who represents growing support for the GOP in the Hispanic community.